Category Archives: Medical

Soligenix CEO to make presentation at ROTH Conference


Christopher Schaber, CEO and president of Soligenix, will make a presentation at the annual ROTH Conference on Tuesday in Dana Point, California, the company said on Thursday. The company has been focusing on vaccination candidates for use in biological defense … Read More »

PositiveID files Firefly Dx patent


The PositiveID Corporation filed a patent on Wednesday for their polymerase chain reaction (PCR) pathogen detection system, called Firefly Dx. The device is able to deliver diagnostic results in a handheld device within 20 minutes. “This patent filing demonstrates the … Read More »

NRC releases PEO ACWA study

Assembled Chemical Weapons Alternatives Program Executive Officer Conrad Whyne

The Program Executive Office, Assembled Chemical Weapons Alternatives (PEO ACWA) announced on Monday that the National Research Council (NRC) has released a study on hydrolysate treatment. This study aimed to review the criteria of treatment of chemical weapons and byproducts … Read More »

Soligenix unveils promising Rivax preclinical data


Soligenix presented promising data from preclinical trials of RiVax, its ricin toxin vaccine, at the American Society of Microbiology Biodefense and Emerging Diseases Research meeting held in Washington, DC last month. The 12 non-human primates that received the vaccine developed neutralizing … Read More »

Multi-step strip could be used to detect Ebola, other diseases


University of Rhode Island (URI) engineers have developed a paper-based diagnostic tool that uses fluid-activated valves to allow multiple steps in the detection of Ebola and other diseases, the university announced Monday. Paper-based options have been available for tests only … Read More »

EU gives overview in Ebola outbreak


Representatives from the European Union (EU) and the European Commission will meet Tuesday to address the ongoing outbreak of Ebola virus affecting West Africa and to adapt an emergency response with a focus on eradicating the disease and establishing long-term support … Read More »

Human trial for Ebola drug ZMapp begins in Liberia


A human safety and efficacy trial for an experimental Ebola virus drug treatment opened on Friday in Liberia. The drug, ZMapp, was developed by Mapp Biopharmaceutical and utilizes monoclonal antibodies to neutralize progression of the disease and deactivate the virus. … Read More »

Marburg immunity development identified


The University of Texas Medical Branch (UTMB) announced Thursday that a team of researchers collaborating with Vanderbilt University and The Scripps Research Institute has identified immunity development in Marburg virus cases. The study consisted of using a blood sample taken … Read More »

2014 PHEMCE strategy and implementation plan released


The Department of Health and Human Services (HHS) released the 2014 Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) Strategy and Implementation Plan on Tuesday. HHS officials say national health security is bolstered by development of medical countermeasures, specifically with regard … Read More »

Tekmira updates board after OnCore Biopharma partnership


Tekmira Pharmaceuticals Corp. said on Wednesday that it is changing its board of directors members as part of its business combination with OnCore Biopharma, Inc. The newly combined company’s board will include Chairman of the Board Vivek Ramaswamy, Richard Henriques Jr., … Read More »

FDA and WHO grant Corgenix emergency Ebola rapid diagnostic test use

ebola (2)

Corginex Medical Corp., a company that develops and sells diagnostic test kits, recently received emergency use authorization from the Food and Drug Administration (FDA) to use its ReEBOV™ Antigen Rapid Test to detect the Ebola virus in West Africa. It is … Read More »

iBio unveils anthrax antibody patent


IBio, Inc. announced Wednesday it has received a patent for plant-based immunoglobins or antibodies that were shown to be effective against anthrax in early animal models. According to company Vice President Wayne Fitzmaurice, this antibody development technology expands product candidacy … Read More »

Subjects for Ebola vaccine trial exceeding target

Dr. Stephen Kennedy

The number of volunteers for clinical trials on two Ebola virus disease vaccines has exceeded expectations, researchers said Monday. Stephen Kennedy, co-investigator for the Clinical Research Partnership between Liberia and the U.S., said the trial target of 600 subjects has … Read More »

Schumer announces over $32 million in funding to cover Ebola costs

Sen. Charles Schumer (D-N.Y.)

Sen. Charles Schumer (D-NY) announced Friday that  after successful Ebola virus preparedness training, New York was the recipient of federal funding from the Department of Health and Human Services (HHS). Preparation for Ebola and the successful treatment of one patient had … Read More »

HHS to fund Ebola preparedness efforts


The Department of Health and Human Services Security (HHS) will invest $194.5 million in health care system preparedness and response to Ebola, and the development of a regional Ebola treatment strategy. HHS will offer the funds to states and other entities … Read More »